Loading...
Please wait, while we are loading the content...
Similar Documents
Targeting BCR-ABL and JAK2 in Ph+ ALL
| Content Provider | Scilit |
|---|---|
| Author | Hantschel, Oliver |
| Copyright Year | 2015 |
| Description | In this issue of Blood, Appelmann et al provide evidence for prolonged survival and prevention of resistance in a mouse model of Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) by combined targeting of the BCR-ABL kinase and Janus kinase 2 (JAK2) with dasatinib and ruxolitinib, respectively. |
| Related Links | http://www.bloodjournal.org/content/bloodjournal/125/9/1362.full.pdf |
| Ending Page | 1363 |
| Page Count | 2 |
| Starting Page | 1362 |
| DOI | 10.1182/blood-2014-12-617548 |
| Journal | Blood |
| Issue Number | 9 |
| Volume Number | 125 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2015-02-26 |
| Access Restriction | Open |
| Subject Keyword | Hematology Oncology Targeting Bcr Bcr Abl Jak2 Acute Lymphoblastic Leukemia Chromosome Mouse Model Prevention Resistance Kinase and Janus Journal: Blood (Vol- 110, Issue- 9) |
| Content Type | Text |
| Resource Type | Article |